Magnesium Acetate

Basic Information

Item Value
DrugBank ID DB13996
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 28

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 hypertensive disorder KG + DL
2 pulmonary hypertension with unclear multifactorial mechanism KG + DL
3 pulmonary hypertension owing to lung disease and/or hypoxia KG + DL
4 malignant renovascular hypertension KG + DL
5 malignant hypertensive renal disease KG + DL
6 Braddock syndrome KG + DL
7 chronic pulmonary heart disease KG + DL
8 gout KG + DL
9 open-angle glaucoma KG + DL
10 potassium deficiency disease KG + DL
11 peptic ulcer disease KG + DL
12 primary hereditary glaucoma KG + DL
13 congestive heart failure KG + DL
14 gastroduodenitis KG + DL
15 renal tubular acidosis KG + DL
16 acute pulmonary heart disease KG + DL
17 Raynaud disease KG + DL
18 alopecia KG + DL
19 chronic renal failure syndrome KG + DL
20 congenital hypotrichosis milia KG + DL
21 hypotrichosis simplex of the scalp KG + DL
22 diffuse alopecia areata KG + DL
23 transient ischemic attack (disease) KG + DL
24 myocardial infarction KG + DL
25 posterolateral myocardial infarction KG + DL
26 posteroinferior myocardial infarction KG + DL
27 chronic kidney disease KG + DL
28 septal myocardial infarction KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.